News

Technology News

Aerpio Therapeutics Raises Venture Capital Debt

Tuesday, April 19, 2016 5:01:00 AM PDT | VentureDeal


Cincinnati, Ohio  --  Biotechnology company Aerpio Therapeutics has received $4.5 million in new debt financing, according to an SEC regulatory filing.

Aerpio says that it is developing new small molecules and monoclonal antibodies for the treatment of vascular disease.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

A total of 54 investors participated in the offering.

Aerpio is still seeking $4.66 million in additional debt investment, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1